BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Zhang W, Tian X. The pleiotropic of GLP-1/GLP-1R axis in central nervous system diseases. Int J Neurosci 2021;:1-38. [PMID: 33941038 DOI: 10.1080/00207454.2021.1924707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Mei A, Wei Y, Li C, Qian H, Min X, Yang H, Dong L, Rao X, Zhong J. GLP-1 receptor agonist as a modulator of innate immunity. Front Immunol 2022;13:997578. [PMID: 36569936 DOI: 10.3389/fimmu.2022.997578] [Reference Citation Analysis]
2 Du H, Meng X, Yao Y, Xu J. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease. Front Endocrinol (Lausanne) 2022;13:1033479. [PMID: 36465634 DOI: 10.3389/fendo.2022.1033479] [Reference Citation Analysis]
3 Yu L, Li Y. Involvement of Intestinal Enteroendocrine Cells in Neurological and Psychiatric Disorders. Biomedicines 2022;10:2577. [PMID: 36289839 DOI: 10.3390/biomedicines10102577] [Reference Citation Analysis]
4 Sango K, Takaku S, Tsukamoto M, Niimi N, Yako H. Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies. Front Cell Dev Biol 2022;10:950623. [PMID: 35874814 DOI: 10.3389/fcell.2022.950623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]